Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emire Seyahi

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Seminars in Arthritis and Rheumatism|February 10, 2025
Venous ulcers in Behçet syndromeAlican Karakoc, Yesim Ozguler, Ayse Ozdede, et al.
Journal of Medical Virology|March 22, 2022
Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquineMert Oztas, Murat Bektas, Ilker Karacan, et al.
Seminars in Arthritis and Rheumatism|July 14, 2024
Brain white matter microstructural alterations in Behcet's syndrome correlate with cognitive impairment and disease severity: A diffusion tensor imaging studyOsman Aykan Kargin, Serdar Arslan, Bora Korkmazer, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Biosimilar infliximab for Behçet's syndrome: a case seriesElif Dincses, Sinem Nihal Esatoglu, Yesim Ozguler, et al.
Clinical and Experimental Rheumatology|June 29, 2026
Socioeconomic status in Behçet's syndromeTumay Ak, Sabriye Güner, Busra Albayrak, et al.
Rheumatology (Oxford, England)|August 7, 2024
De novo manifestations during adalimumab treatment in Behçet's syndromeSinem Nihal Esatoglu, Ozge Sonmez, Didar Ucar, et al.
Rheumatology International|July 6, 2021
Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination ratesAysa Hacioglu, Sermin Borekci, Melike Melikoglu, et al.
Rheumatology (Oxford, England)|December 27, 2021
Emergence of new manifestations during infliximab treatment in Behçet's syndromeNur Beyza Tukek, Sinem Nihal Esatoglu, Gulen Hatemi, et al.
Frontiers in Immunology|May 3, 2021
COVID-19 Among Patients With Inflammatory Rheumatic DiseasesSinem Nihal Esatoglu, Koray Tascilar, Hakan Babaoğlu, et al.
Clinical and Experimental Rheumatology|July 14, 2025
Turkish Society for Rheumatology (Turkish Takayasu Arteritis Study Group) recommendations for the diagnosis, follow-up and the treatment of Takayasu's arteritisFatma Alibaz-Öner, Sema Kaymaz-Tahra, Burak Ince, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Seminars in Arthritis and Rheumatism|February 10, 2025
Venous ulcers in Behçet syndromeAlican Karakoc, Yesim Ozguler, Ayse Ozdede, et al.
Journal of Medical Virology|March 22, 2022
Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquineMert Oztas, Murat Bektas, Ilker Karacan, et al.
Seminars in Arthritis and Rheumatism|July 14, 2024
Brain white matter microstructural alterations in Behcet's syndrome correlate with cognitive impairment and disease severity: A diffusion tensor imaging studyOsman Aykan Kargin, Serdar Arslan, Bora Korkmazer, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Biosimilar infliximab for Behçet's syndrome: a case seriesElif Dincses, Sinem Nihal Esatoglu, Yesim Ozguler, et al.
Clinical and Experimental Rheumatology|June 29, 2026
Socioeconomic status in Behçet's syndromeTumay Ak, Sabriye Güner, Busra Albayrak, et al.
Rheumatology (Oxford, England)|August 7, 2024
De novo manifestations during adalimumab treatment in Behçet's syndromeSinem Nihal Esatoglu, Ozge Sonmez, Didar Ucar, et al.
Rheumatology International|July 6, 2021
Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination ratesAysa Hacioglu, Sermin Borekci, Melike Melikoglu, et al.
Rheumatology (Oxford, England)|December 27, 2021
Emergence of new manifestations during infliximab treatment in Behçet's syndromeNur Beyza Tukek, Sinem Nihal Esatoglu, Gulen Hatemi, et al.
Frontiers in Immunology|May 3, 2021
COVID-19 Among Patients With Inflammatory Rheumatic DiseasesSinem Nihal Esatoglu, Koray Tascilar, Hakan Babaoğlu, et al.
Clinical and Experimental Rheumatology|July 14, 2025
Turkish Society for Rheumatology (Turkish Takayasu Arteritis Study Group) recommendations for the diagnosis, follow-up and the treatment of Takayasu's arteritisFatma Alibaz-Öner, Sema Kaymaz-Tahra, Burak Ince, et al.
Pageof 12